The global HIV pandemic is estimated to currently infect 35 million people and 25% of people with HIV in the UK are unaware of their infection.
The enormous scale of the HIV pandemic means there is a desperate need for early detection systems to prevent the spread of this infection. This is driving the development of new mobile phone-connected technologies to test and track HIV in resource-limited settings and feed into global health surveillance systems.
Led by Professor Molly Stevens, Flagship 4 is carrying out early-stage research to develop low-cost nanoparticle‐paper microfluidic tests, to detect ultra‐low levels of HIV biomarkers. Microfluidic chips will be connected with mobile phones, allowing testing in all reaches of society, from a local community centre in East London to resource poor communities in rural South Africa. Results will be transmitted to surveillance systems using mobile phone cameras and low‐power CMOS.
Find out more about HIV.